Due to the special nature of medicines, returns and exchanges are not supported.

Final delivery from the nearest overseas warehous NEW

Darzalex Faspro兆珂SC

Daratumumab subcutaneous injection, English trade name: DARZALEX FASPRO®) has been approved by the National Medical Products Administration (NMPA) for the treatment of patients with multiple myeloma.

Categories: Breast glands and blood, Oncology drugs

Share:

Health Classification

Let us work together to protect precious health

More